FDA NDC
MYDAYIS
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 54092-468
- Proprietary name
- MYDAYIS
- Nonproprietary name
- DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Strength
- 3.125 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.